Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Global Antimicrobial Resistance|May 19, 2018
Is meropenem MIC increase against KPC-producing Klebsiella pneumoniae correlated with increased resistance rates against other antimicrobials with Gram-negative activity?Piergiorgio Cojutti, Assunta Sartor, Matteo Bassetti, et al.
Journal of Public Health Research|January 14, 2017
Monitoring Polypharmacy in Healthcare Systems Through a Multi-Setting Survey: Should We Put More Attention on Long Term Care Facilities?Luca Arnoldo, Giovanni Cattani, Piergiorgio Cojutti, et al.
The Journal of Antimicrobial Chemotherapy|September 4, 2014
Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulationPiergiorgio Cojutti, Natalia Maximova, Giovanni Crichiutti, et al.
Diagnostic Microbiology and Infectious Disease|October 11, 2014
A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast ItalyPiergiorgio Cojutti, Claudio Scarparo, Assunta Sartor, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2013
Antifungal prophylaxis with posaconazole in patients with acute myeloid leukemia: dose intensification coupled with avoidance of proton pump inhibitors is beneficial in shortening time to effective concentrationsPiergiorgio Cojutti, Anna Candoni, Erica Simeone, et al.
Antimicrobial Agents and Chemotherapy|February 29, 2012
Successful long-term treatment of cerebral nocardiosis with unexpectedly low doses of linezolid in an immunocompromised patient receiving complex polytherapyFederico Pea, Piergiorgio Cojutti, Alberto Pagotto, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2017
Population Pharmacokinetics of High-Dose Continuous-Infusion Meropenem and Considerations for Use in the Treatment of Infections Due to KPC-Producing Klebsiella pneumoniaePiergiorgio Cojutti, Assunta Sartor, Elda Righi, et al.
The Journal of Antimicrobial Chemotherapy|May 4, 2012
Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patientsFederico Pea, Pierluigi Viale, Piergiorgio Cojutti, et al.
Antimicrobial Agents and Chemotherapy|August 25, 2010
Therapeutic drug monitoring of linezolid: a retrospective monocentric analysisFederico Pea, Mario Furlanut, Piergiorgio Cojutti, et al.
The Journal of Antimicrobial Chemotherapy|February 3, 2016
Might isoniazid plasma exposure be a valuable predictor of drug-related hepatotoxicity risk among adult patients with TB?Piergiorgio Cojutti, Silvia Duranti, Miriam Isola, et al.
Pageof 4